You searched for T cells - Page 19 of 41

News and Trends 10 Nov 2022

SOTIO reveal potential treatment for adults with solid tumors at SITC meeting

…therapy has made significant strides in the treatment of hematological malignancies, yet solid tumors remain resistant to current CAR-T strategies due to suppression by the tumor microenvironment. “The preclinical data…

November 10, 2022 - 4 minutesmins - By Liza Laws

In Depth 25 Dec 2024

When biotech makes Christmas miracles a reality

…explore alternative options. They turned to trametinib, a drug initially developed to treat melanoma. This targeted therapy inhibits MEK1 and MEK2, proteins that play a crucial role in the MAPK/ERK…

December 25, 2024 - 8 minutesmins - By Jules Adam

Best in Biotech 2 Sep 2021

The top 15 biotech companies to find in the Netherlands

…top of chemotherapy. Lava Therapeutics Founded: 2016 Lava Therapeutics develops cancer immunotherapies that use antibodies to recruit gamma-delta T cells – a type of immune cells that are naturally involved…

September 2, 2021 - 7 minutesmins - By Clara Rodríguez Fernández

cancer immunotherapy stipe therapeutics novo holdings arix

News and Trends 30 Sep 2019

€20M Series A Launches Cancer Immunotherapy Biotech in Denmark

…tumor cells. This signal then tells immune cells in the tumor microenvironment to attack the tumor. STipe’s treatments are designed to make the immune cells’ STING alarm signal more sensitive…

September 30, 2019 - 2 minutesmins - By Jonathan Smith

Altheia Science gene therapy autoimmune disease

News and Trends 19 Dec 2018

Italian Biotech Raises Big Series A for ‘Gene Therapy 2.0’

…would be the first gene therapy to target a disease that is not caused by a single gene. “This opens the path to gene therapy 2.0, where the target includes…

December 19, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

In Depth 30 Dec 2020

A Look Back at the Past Decade of European Biotech

…saw the US approval of Kymriah, the world’s first CAR-T cell therapy. This treatment consists of engineering the patient’s own immune cells to make them better at identifying and attacking…

December 30, 2020 - 15 minutesmins - By Karen O’Hanlon Cohrt

Best in Biotech 10 Oct 2017

Buongiorno Biotech! Top 4 Companies Making Milan Europe’s Next Biotech Hub

…things Italian biotech, went as far as to tell me: “The aim should be to produce a few more ‘Genentas’.” The biotech takes on the immunosuppressive environment that a tumor…

October 10, 2017 - 7 minutesmins - By Alex Dale

In Depth 29 Jan 2025

Pancreatic cancer: Oncolytics Biotech, Candel, and CytomX bring promising therapies to the clinic

…is pancreatic cancer so difficult to treat and what drugs are currently in the therapeutic pipeline? Table of contents Why is pancreatic cancer so difficult to treat? There are several…

January 29, 2025 - 8 minutesmins - By Willow Shah-Neville

News and Trends 7 Jun 2017

What Cancer Therapies did European Biotechs Showcase at ASCO 2017?

…trial, planned to start later this year, that will test whether IO102, a peptide vaccine against the indoleamine 2,3-dioxygenase (IDO) enzyme, can boost the activity of an anti-PD1 checkpoint inhibitor…

June 7, 2017 - 5 minutesmins - By Clara Rodríguez Fernández

News and Trends 8 Nov 2022

Collaboration to develop CAR-T cell therapy for cutaneous T-cell lymphoma

…treated are reprogrammed to bind specifically to the tumor cells expressing TAG-72. Upon infusion into the patient, the CTH-001 CAR-T cells are expected to destroy the CTCL-associated malignant T cells. …

November 8, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 6 Nov 2018

Potential HIV Treatment Shows Early Stage Promise

…the enzyme that HIV uses to insert viral DNA into the host cell’s genome. Integrase then inserts too much viral DNA into the cell, blowing the virus’s cover and making…

November 6, 2018 - 3 minutesmins - By Jonathan Smith

News and Trends 23 Jul 2018

Sangamo Acquires French Biotech to Develop CAR-T Therapies for Autoimmune Disease

…white blood cells and genetically engineering them to recognize cancer cells. The cells are then reintroduced into the patient, where they attack and kill cancer cells. While most CAR-T-cell therapy…

July 23, 2018 - 3 minutesmins - By Alexander Burik

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: T cells

SOTIO reveal potential treatment for adults with solid tumors at SITC meeting

When biotech makes Christmas miracles a reality

The top 15 biotech companies to find in the Netherlands

€20M Series A Launches Cancer Immunotherapy Biotech in Denmark

Italian Biotech Raises Big Series A for ‘Gene Therapy 2.0’

A Look Back at the Past Decade of European Biotech

Buongiorno Biotech! Top 4 Companies Making Milan Europe’s Next Biotech Hub

Pancreatic cancer: Oncolytics Biotech, Candel, and CytomX bring promising therapies to the clinic

What Cancer Therapies did European Biotechs Showcase at ASCO 2017?

Collaboration to develop CAR-T cell therapy for cutaneous T-cell lymphoma

Potential HIV Treatment Shows Early Stage Promise

Sangamo Acquires French Biotech to Develop CAR-T Therapies for Autoimmune Disease

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!